Company Filing History:
5 out of 47 
1 out of 1 
1 out of 4 Years Active: 1996-2005
Title: The Innovative Contributions of John H. Staniforth
Introduction
John H. Staniforth, an esteemed inventor based in Bath, Great Britain, has made significant contributions to the pharmaceutical industry through his innovative work. With a total of seven patents to his name, Staniforth has demonstrated a commitment to advancing technology and improving formulations in this critical field.
Latest Patents
Among his latest inventions, Staniforth has developed a pharmaceutical excipient that boasts improved compressibility. This microcrystalline cellulose-based excipient is designed for use in various formulations, including direct compression, dry granulation, and wet granulation. The invention features an agglomerate of microcrystalline cellulose particles, combined with silicon dioxide particles ranging from 0.1% to 20% by weight. Notably, the silicon dioxide used has a particle size of approximately 1 nanometer to 100 microns, with colloidal silicon dioxide being the preferred grade. This innovation enhances the efficiency and effectiveness of pharmaceutical preparations, showcasing Staniforth's inventive prowess.
Career Highlights
Over the years, John H. Staniforth has showcased his talent while working at notable companies, including Edward Mendell Co., Inc. and Edward H. Mendell Co., Inc. His experiences in these organizations have granted him a platform to refine his skills and contribute to significant advancements in product formulation.
Collaborations
Staniforth has collaborated with various professionals throughout his career, including notable colleagues such as Bob E. Sherwood and Edward A. Hunter. These partnerships have proven fruitful in driving innovation and sharing knowledge in the field of pharmaceutical sciences.
Conclusion
With a strong foundation of seven patents, John H. Staniforth stands out as a pioneering inventor in the realm of pharmaceutical excipients. His latest work, centered on improving compressibility in microcrystalline cellulose formulations, reflects his dedication to enhancing the efficiency of drug delivery systems. Staniforth's contributions continue to influence the industry positively, earning him recognition as a key figure in pharmaceutical innovation.